XML 147 R132.htm IDEA: XBRL DOCUMENT v3.24.3
Share-Based Payments - Summary of Performance Rights Granted (Detail) - Share consolidation adjustment [member]
 12 Months Ended
Jun. 30, 2024
shares
$ / shares
Jun. 30, 2023
shares
$ / shares
Jun. 30, 2022
shares
$ / shares
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Balance at end of the end fiscal year Number 1,893,081 [1] 1,339,621 3,100,000
Granted during the fiscal year Number 768,311 1,624,499 339,621
Exercised during the fiscal year Number (500,000) (706,173) (1,200,000)
Lapsed during the fiscal year Number 0 (364,866) (900,000)
Balance at end of the end fiscal year Number 2,161,392 1,893,081 [1] 1,339,621
Vested and exercisable at end of the fiscal year Number 231,517 0 0
November 16, 2018 [member]      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Grant date November 16, 2018    
Type of performance right granted     Director rights
Fair value | $ / shares     $ 0.39
Balance at end of the end fiscal year Number   0 250,000
Granted during the fiscal year Number     0
Exercised during the fiscal year Number     (250,000)
Lapsed during the fiscal year Number     0
Balance at end of the end fiscal year Number     0
Vested and exercisable at end of the fiscal year Number     0
November 1, 2019 [member]      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Grant date November 1, 2019 November 1, 2019  
Type of performance right granted Director rights Director rights Director rights
Fair value | $ / shares $ 0.28 [1] $ 0.28 $ 0.28
Balance at end of the end fiscal year Number 500,000 [1] 1,000,000 1,500,000
Granted during the fiscal year Number 0 0 0
Exercised during the fiscal year Number (500,000) (500,000) (500,000)
Lapsed during the fiscal year Number 0 0 0
Balance at end of the end fiscal year Number 0 500,000 [1] 1,000,000
Vested and exercisable at end of the fiscal year Number 0 0 0
October 27, 2020 [member]      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Grant date October 27, 2020    
Type of performance right granted     Director rights
Fair value | $ / shares     $ 0.255
Balance at end of the end fiscal year Number   0 1,350,000
Granted during the fiscal year Number     0
Exercised during the fiscal year Number     (450,000)
Lapsed during the fiscal year Number [2]     (900,000)
Balance at end of the end fiscal year Number     0
Vested and exercisable at end of the fiscal year Number     0
November 23, 2022 [member]      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Grant date November 23, 2022 November 23, 2022  
Type of performance right granted Director rights Director rights  
Fair value | $ / shares $ 0.31 [1] $ 0.31  
Balance at end of the end fiscal year Number 1,166,667 [1] 0  
Granted during the fiscal year Number 0 1,166,667  
Exercised during the fiscal year Number 0 0  
Lapsed during the fiscal year Number 0 0  
Balance at end of the end fiscal year Number 1,166,667 1,166,667 [1] 0
Vested and exercisable at end of the fiscal year Number 0 0  
December 1, 2021 [member]      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Grant date December 1, 2021 December 1, 2021  
Type of performance right granted Director rights Director rights Director rights
Fair value | $ / shares $ 0.49 [1] $ 0.49 $ 0.49
Balance at end of the end fiscal year Number 226,414 [1] 339,621 0
Granted during the fiscal year Number 0 0 339,621
Exercised during the fiscal year Number 0 (113,207) 0
Lapsed during the fiscal year Number 0 0 0
Balance at end of the end fiscal year Number 226,414 226,414 [1] 339,621
Vested and exercisable at end of the fiscal year Number 113,207 0 0
November 23, 2022 [member]      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Grant date   November 23, 2022  
Type of performance right granted   Director rights  
Fair value | $ / shares   $ 0.31  
Balance at end of the end fiscal year Number 0 0  
Granted during the fiscal year Number   457,832  
Exercised during the fiscal year Number   (92,966)  
Lapsed during the fiscal year Number [2]   (364,866)  
Balance at end of the end fiscal year Number   0 0
Vested and exercisable at end of the fiscal year Number   0  
October 24, 2023 [Member]      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Grant date October 24, 2023    
Type of performance right granted Director rights    
Fair value | $ / shares [1] $ 0.32    
Balance at end of the end fiscal year Number [1] 0    
Granted during the fiscal year Number 178,356    
Exercised during the fiscal year Number 0    
Lapsed during the fiscal year Number 0    
Balance at end of the end fiscal year Number 178,356 0 [1]  
Vested and exercisable at end of the fiscal year Number 28,356    
October 24, 2023 [Member]      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Grant date October 24, 2023    
Type of performance right granted Director rights    
Fair value | $ / shares [1] $ 0.32    
Balance at end of the end fiscal year Number [1] 0    
Granted during the fiscal year Number 589,955    
Exercised during the fiscal year Number 0    
Lapsed during the fiscal year Number 0    
Balance at end of the end fiscal year Number 589,955 0 [1]  
Vested and exercisable at end of the fiscal year Number 89,954    
[1] The weighted average share price on the exercising date during the financial year 2024 is $0.285.
[2] The change during the year represents derecognition due to the cessation of the director.